Manchester Asthma and Allergy Study - primary prevention of asthma and allergy by allergen avoidance in high risk infants

Not Applicable

Recruiting

• Conditions: Asthma; Respiratory

• Registration Number: ISRCTN63558189
• Lead Sponsor: Wythenshawe Hospital (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-10-19
• Last Update Posted: 4 September 2017

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

High-risk children (both parents atopic) of either sex born at Wythenshawe Hospital Manchester and Stepping Hill Hospital Stockport between January 1996 and April 1998

Exclusion Criteria

Premature birth less than 32 weeks gestation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Asthma at age 5, 8, 11, and 14 years<br>2. Sensitisation at age 1, 3, 5, 8, 11 and 14 years

Secondary Outcome Measures

Name	Time	Method
Wheeze and eczema at age 1, 3, 5, 8, 11 and 14 years